Beyond PIB: The next generation of amyloid-imaging ligands

Psychogeriatrics

Volumn 8, Issue 3, 2008, Pages 105-107

  Shinotoh, Hitoshi ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 [6 [(2 FLUOROETHYL)METHYLAMINO] 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE F 18; 2 [2 (2 DIMETHYLAMINOTHIAZOL 5 YL)ETHENYL] 6 [2 (FLUORO)ETHOXY]BENZOXAZOLE C 11; 2,3 DIHYDRO 1H IMIDAZO[1,2 B]PYRAZOLE; 4 N METHYLAMINO 4' HYDROXYSTILBENE C 11; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; BAPINEUZUMAB; BAY 94 9172; CARBON 11; CHRYSAMINE G; CONGO RED; CORTICOSTERONE; DYE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; IODINE 123; LIGAND; MALONONITRILE; NOOTROPIC AGENT; STILBENE DERIVATIVE; TECHNETIUM 99M; THIOFLAVINE; TRACER; TRANS 4 (N METHYLAMINO) 4' [2 [2 (2 FLUOROETHOXY)ETHOXY]ETHOXY]STILBENE F 18; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOPSY; BLOOD BRAIN BARRIER; CLINICAL TRIAL; COGNITIVE DEFECT; DISEASE SEVERITY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG UPTAKE; EDITORIAL; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; HUMAN; HYDROPHILICITY; ISOTOPE LABELING; LEWY BODY; LIGAND BINDING; LIPOPHILICITY; MOLECULAR IMAGING; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 57249097799     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2008.00246.x     Document Type: Editorial

References (15)

1. Mathis CA, Wang Y, Klunk WE. Imaging β-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr Pharmaceut Design 2004; 10: 1469-1492.
2. Majocha RE, Reno JM, Friedland RP, VanHaight C, Lyle LR, Marotta CA. Development of a monoclonal antibody specific for beta/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. J Nucl Med 1992; 33: 2184-2189.
3. Agdeppa ED, Kepe V, Liu J et al. Binding characteristics of radiofluorinate 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci 2001; 21: RC189.
4. Shoghi-Jadid K, Small GW, Agdeppa ED etal. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002; 10: 23-35.
5. Small GW, Kepe V, Ercoli LM et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006; 355: 2652-2563.
6. Klunk WE, Engler H, Nordberg A et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 303-305.
7. Rowe CC, Ng S, Ackermann U et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007; 68: 1718-1725.
8. 11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 2006; 67: 446-452.
9. Johnson KA, Gregas M, Becker JA et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007; 62: 229-234.
10. 11C]SB-13 PET. Am J Geriatr Psychiatry 2004; 12: 584-595.
11. Kudo Y, Okamura N, Furumoto S et al. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy) benzoxazole: A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med 2007; 48: 553-561.
12. Lockhart A, Lamb JR, Osredkar T et al. PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis. Brain 2007; 130: 2607-2615.
13. Rowe CC, Ackerman U, Browne W et al. Imaging of amyloid beta in Alzheimer's disease with 18 F-BAY94-9172, a novel PET tracer: Proof of mechanism. Lancet Neurol 2008; 7: 129-35.
14. Nakada T, Matsuzawa H, Igarashi H, Fujii Y, Kwee IL. In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system. J Neuroimaging 2008; 18: 125-129.
15. Salloway S, Mintzer J, Weiner MF, Cummings JL. Disease-modifying therapies in Alzheimer's disease. Alzheimer Dement 2008; 4: 65-79.